CorMedix Inc.

1. 01

   Below its 50- and 200-day averages

   The 4 Nov 2026 close of $5.66 was 25.8% below its 50-day average ($7.63) and 26.0% below its 200-day average ($7.65). It has closed below the 200-day for 5 sessions, since 29 Oct 2026. The 50-day average crossed below the 200-day on 4 Nov 2026, in the latest session.

   Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026

2. 02

   Behind SPY and its sector fund XLV over 1 year

   1 month: −22.3% (SPY −1.6%, XLV +13.5%). 3 months: −23.6% (SPY −0.4%, XLV +15.5%). 1 year: −50.4% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.

   Daily closes, split-adjusted: CRMD, SPY and XLV · as of 4 Nov 2026

3. 03

   6.8% above its 52-week low

   Closed at $5.66 on 4 Nov 2026: 56.5% below the 52-week high of $13.02 (30 Dec 2025) and 6.8% above the low of $5.30 (3 Nov 2026).

   Daily price bars, split-adjusted · as of 4 Nov 2026

4. 04

   12.7 days to cover short interest

   14.7M shares were sold short at the 15 Oct 2026 settlement, 18.8% of the 77.9M shares outstanding; covering them would take 12.7 days of average volume. Short interest is reported twice a month, on a lag.

   Exchange short-interest filing · as of 15 Oct 2026

5. 05

   Volume 2.6× its 30-session average on 2 Nov 2026

   2 Nov 2026 volume of 3.3M shares was 2.6× the average of the 30 sessions before it (1.3M), as the price fell 5.4%. SPY traded 1.2× its own average that session.

   Daily volume against a 30-session baseline · as of 2 Nov 2026

At the 4 Nov 2026 close